<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Arq. Bras. Cardiol</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26352181</article-id>
      <article-id pub-id-type="pmc">4559132</article-id>
      <article-id pub-id-type="doi">10.5935/abc.20150100</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Profound Sustained Hypotension Following Renal Denervation: A Dramatic
Success?</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Sridhar</surname>
            <given-names>Ganiga Srinivasaiah</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Watson</surname>
            <given-names>Timothy</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="aff" rid="aff02">2</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Han</surname>
            <given-names>Chee Kok</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ahmad</surname>
            <given-names>Wan Azman Wan</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label>Departamento de Cardiologia - Universidade Malaya Medical Center - Kuala
Lumpur Malaysia</aff>
      <aff id="aff02"><label>2</label>Departamento de Medicina - Universidade de Auckland - Auckland, New
Zealand</aff>
      <author-notes>
        <corresp id="c01"><bold>Mailing Address: Timothy Watson</bold>, Department of
Cardiology, University Malaya, Lembah Pantai, Postal Code 59100, Kuala Lumpur,
Malaysia. Email: <email>tjw123@me.com</email></corresp>
        <fn fn-type="con">
          <p>
            <bold>Author contributions</bold>
          </p>
          <p>Acquisition of data: Sridhar GS, Han CK, Ahmad WAW; Writing of the manuscript:
Sridhar GS, Watson T, Han CK, Ahmad WAW; Critical revision of the manuscript for
intellectual content: Watson T.</p>
        </fn>
        <fn fn-type="conflict">
          <p>
            <bold>Potential Conflict of Interest</bold>
          </p>
          <p>No potential conflict of interest relevant to this article was reported.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <month>8</month>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <month>8</month>
        <year>2015</year>
      </pub-date>
      <volume>105</volume>
      <issue>2</issue>
      <fpage>202</fpage>
      <lpage>204</lpage>
      <history>
        <date date-type="received">
          <day>26</day>
          <month>7</month>
          <year>2014</year>
        </date>
        <date date-type="rev-recd">
          <day>21</day>
          <month>8</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>06</day>
          <month>10</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly
cited.</license-p>
        </license>
      </permissions>
      <kwd-group>
        <kwd>Hypertension</kwd>
        <kwd>Sympatectomy</kwd>
        <kwd>Medication Therapy</kwd>
        <kwd>Management</kwd>
        <kwd>Hypotension</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>A 67-year-old woman with drug-refractory essential hypertension was admitted for renal
sympathetic denervation (RDN). The secondary causes of hypertension were fully
investigated in this patient. A 24-h ambulatory blood pressure (BP) monitor documented a
mean daytime BP of 172/101 mmHg, a mean nighttime BP of 151/84 mmHg, and an overall mean
BP of 167/97 mmHg despite compliance with metoprolol (50 mg twice daily), amlodipine (10
mg once daily), lisinopril (20 mg once daily), prazosin (2 mg thrice daily), and
hydrochlorothiazide (50 mg once daily).</p>
      <p>The patient was fasted for 4 h. Her usual antihypertensive drug therapy was continued.
After the administration of 5,000 international units of heparin and 100
<italic>&#x3BC;</italic>g of fentanyl, a 7-F Renal Double Curve guide catheter (Cordis
Corporation, Fremont, CA ,USA) was inserted into the right renal artery (no accessory
vessel). A 0.014-in Runthrough floppy guide wire (Terumo Medical Corporation, Somerset,
NJ, USA) was advanced into place. A 6-mm ONESHOT<sup>TM</sup> (Covidien, Mansfield, MA,
USA) irrigated RDN balloon was advanced into place (<xref ref-type="fig" rid="f01">Figure 1</xref>), and a single ablation was performed. The procedure was then
repeated on the other side. The patient remained hemodynamically stable throughout and
at the completion of the procedure with a BP of 150/80 mmHg. Hemostasis was achieved
with the Perclose ProGlide Suture-Mediated Closure System (Abbott Vascular, Santa Clara,
CA, USA), and the patient was then returned to our ward for monitoring.</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Renal Denervation Procedure. Selective angiography performed with a 7-F Renal
Double Curve guide catheter in the left anterior oblique 10&#xB0; projection. Note that
a single renal artery supplies each kidney and that the caliber and length of the
main renal artery prior to bifurcation is ideally suited to denervation.</p>
        </caption>
        <graphic xlink:href="abc-105-02-0202-g01"/>
      </fig>
      <p>One hour later, the patient complained of dizziness and blurring of vision. Her Glasgow
Coma Scale score remained 15 with preserved mentation. She was not in pain. Her pulse
rate was 87 bpm, and her BP was 77/38 mmHg. However, she appeared well perfused and was
clinically euvolemic. There was no evidence of a groin hematoma, and her abdomen was
soft. A 12-lead electrocardiogram showed no change, and a transthoracic echocardiogram
showed normal left ventricular function. Her hemoglobin level was similar to baseline,
and her arterial blood gas levels, including lactate, were unremarkable.</p>
      <p>She was given intravenous dopamine that was titrated to response. At 10
<italic>&#x3BC;</italic>g/kg/min, her BP rose to 120/70 mmHg, and her symptoms resolved
entirely. Over the subsequent 48 h, she was extremely sensitive to reductions in the
dose of dopamine and exhibited a markedly fluctuating BP. However, by 72 h, the dopamine
had been carefully weaned and discontinued. She was discharged home after she remained
stable for a further 24 h. At a 3-month review, she remains well with a mean daytime
office BP of 124/72&#xA0;mmHg while on amlodipine (5 mg once daily).</p>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>Around 12% of patients with essential hypertension who are considered resistant to
conventional therapy have persistently elevated BP despite the use of three or more
pharmacological agents<sup><xref rid="B01" ref-type="bibr">1</xref>,<xref rid="B02" ref-type="bibr">2</xref></sup>. In such instances, abnormal renal
excretory function, which is largely influenced by renal sympathetic nerve activity, may
have a central role<sup><xref rid="B03" ref-type="bibr">3</xref></sup>. Catheter-based
RDN, which is a modern incarnation of a historically effective treatment, has recently
emerged as a novel therapeutic strategy. Proof of concept and subsequent randomized
(unblinded) data that were collected while using the Symplicity<bold>&#xAE;</bold> catheter
(Medtronic, Inc., Minneapolis, MN, USA) have demonstrated reductions in office BP of
20/10, 24/11, 25/11, and 23/11 mmHg at 1, 3, 6, and 12&#xA0;months, respectively, in a group
of patients taking an average of five antihypertensive drugs<sup><xref rid="B04" ref-type="bibr">4</xref>,<xref rid="B05" ref-type="bibr">5</xref></sup>. Such early
exciting reports have stimulated the development of numerous other similar devices,
including the ONESHOT<sup>TM</sup> catheter that was used in this case<sup><xref rid="B06" ref-type="bibr">6</xref></sup>.</p>
      <p>In some cases, early BP reductions have been reported following RDN. However, in other
cases, the response is not always immediate, or it can take several months to appear.
Additionally, RDN is associated with a failure rate of 10%-30%, and the only predictor
of response in early studies is the magnitude of the systolic BP elevation at
baseline<sup><xref rid="B07" ref-type="bibr">7</xref></sup>. Explanations for this
broad variability in outcome are uncertain, except that raw BP measurements may lack the
sensitivity required for them to be considered a true measure of successful
RDN<sup><xref rid="B08" ref-type="bibr">8</xref></sup>. This may in part explain
the lackluster performance of RDN in the Symplicity-3 trial, in which RDN failed to
demonstrate superiority over conventional treatments when compared to a sham-control
procedure<sup><xref rid="B09" ref-type="bibr">9</xref></sup>. However, despite
this, the use of RDN does seem to significantly reduce renal norepinephrine
spillover<sup><xref rid="B10" ref-type="bibr">10</xref></sup>. Therefore, it is
possible that those patients who exhibit more sympathetic over-activity may experience a
greater degree of BP reduction with RDN. Because sympathetic over-activity is not
routinely measured in clinical practice, this remains speculative.</p>
      <p>Nonetheless, the role of RDN in the treatment of resistant hypertension remains
uncertain, but the sustained and impressive BP reductions that were observed in this and
other cases should encourage further research to improve the understanding of the
mechanisms through which hypertension is mediated and to identify those patients who are
likely to achieve the most dramatic responses with RDN.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="supported-by">
        <p>
          <bold>Sources of Funding</bold>
        </p>
        <p>There were no external funding sources for this study.</p>
      </fn>
      <fn fn-type="other">
        <p>
          <bold>Study Association</bold>
        </p>
        <p>This study is not associated with any thesis or dissertation work.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="B01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Persell</surname>
              <given-names>SD</given-names>
            </name>
          </person-group>
          <article-title>Prevalence of resistant hypertension in the United States,
2003-2008</article-title>
          <source>Hypertension</source>
          <year>2011</year>
          <volume>57</volume>
          <issue>6</issue>
          <fpage>1076</fpage>
          <lpage>1080</lpage>
          <pub-id pub-id-type="pmid">21502568</pub-id>
        </element-citation>
      </ref>
      <ref id="B02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mancia</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Fagard</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Narkiewicz</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Redon</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zanchetti</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>B&#xF6;hm</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>2013 ESH/ESC guidelines for the management of arterial hypertension:
the Task Force for the Management of Arterial Hypertension of the European Society
of Hypertension (ESH) and of the European Society of Cardiology
(ESC)</article-title>
          <source>Eur Heart J</source>
          <year>2013</year>
          <volume>34</volume>
          <issue>28</issue>
          <fpage>2159</fpage>
          <lpage>2219</lpage>
          <pub-id pub-id-type="pmid">23771844</pub-id>
        </element-citation>
      </ref>
      <ref id="B03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>DiBona</surname>
              <given-names>GF</given-names>
            </name>
          </person-group>
          <article-title>The sympathetic nervous system and hypertension: recent
developments</article-title>
          <source>Hypertension</source>
          <year>2004</year>
          <volume>43</volume>
          <issue>2</issue>
          <fpage>147</fpage>
          <lpage>150</lpage>
          <pub-id pub-id-type="pmid">14707153</pub-id>
        </element-citation>
      </ref>
      <ref id="B04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krum</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Barman</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Schlaich</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sobotka</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Esler</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mahfoud</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
            <collab>Symplicity HTN-1 Investigators</collab>
          </person-group>
          <article-title>Catheter-based renal sympathetic denervation for resistant
hypertension: durability of blood pressure reduction out to 24
months</article-title>
          <source>Hypertension</source>
          <year>2011</year>
          <volume>57</volume>
          <issue>5</issue>
          <fpage>911</fpage>
          <lpage>917</lpage>
          <pub-id pub-id-type="pmid">21403086</pub-id>
        </element-citation>
      </ref>
      <ref id="B05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Esler</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Krum</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sobotka</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Schlaich</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Schmieder</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Bohm</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Renal sympathetic denervation in patients with treatment-resistant
hypertension (The Symplicity HTN-2 Trial): a randomised controlled
trial</article-title>
          <source>Lancet</source>
          <year>2010</year>
          <volume>376</volume>
          <issue>9756</issue>
          <fpage>1903</fpage>
          <lpage>1909</lpage>
          <pub-id pub-id-type="pmid">21093036</pub-id>
        </element-citation>
      </ref>
      <ref id="B06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ormiston</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Watson</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>van Pelt</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Stewart</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Stewart</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>JM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Renal denervation for resistant hypertension using an irrigated
radiofrequency balloon: 12-month results from the Renal Hypertension Ablation
System (RHAS) trial</article-title>
          <source>Eurointervention</source>
          <year>2013</year>
          <volume>9</volume>
          <issue>1</issue>
          <fpage>70</fpage>
          <lpage>74</lpage>
          <pub-id pub-id-type="pmid">23685297</pub-id>
        </element-citation>
      </ref>
      <ref id="B07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thomas</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Shishehbor</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Bravo</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Nally</surname>
              <given-names>JV</given-names>
            </name>
          </person-group>
          <article-title>Renal denervation to treat resistant hypertension: guarded
optimism</article-title>
          <source>Cleve Clin J Med</source>
          <year>2012</year>
          <volume>79</volume>
          <issue>7</issue>
          <fpage>501</fpage>
          <lpage>510</lpage>
          <pub-id pub-id-type="pmid">22751635</pub-id>
        </element-citation>
      </ref>
      <ref id="B08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sathananthan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Watson</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Whitbourn</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Stewart</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Doughty</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>Ormiston</surname>
              <given-names>JA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Renal sympathetic denervation: indications, contemporary devices and
future directions</article-title>
          <source>Interv Cardiol</source>
          <year>2014</year>
          <volume>6</volume>
          <issue>1</issue>
          <fpage>57</fpage>
          <lpage>69</lpage>
        </element-citation>
      </ref>
      <ref id="B09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bhatt</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Kandzari</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>O'Neill</surname>
              <given-names>WW</given-names>
            </name>
            <name>
              <surname>D'Agostino</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Flack</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Katzen</surname>
              <given-names>BT</given-names>
            </name>
            <etal/>
            <collab>SYMPLICITY HTN-3 Investigators</collab>
          </person-group>
          <article-title>A controlled trial of renal denervation for resistant
hypertension</article-title>
          <source>N Engl J Med</source>
          <year>2014</year>
          <volume>370</volume>
          <issue>15</issue>
          <fpage>1393</fpage>
          <lpage>1401</lpage>
          <pub-id pub-id-type="pmid">24678939</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krum</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Schlaich</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Whitbourn</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sobotka</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Sadowski</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bartus</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Catheter-based renal sympathetic denervation for resistant
hypertension: a multicentre safety and proof-of-principle cohort
study</article-title>
          <source>Lancet</source>
          <year>2009</year>
          <volume>373</volume>
          <issue>9671</issue>
          <fpage>1275</fpage>
          <lpage>1281</lpage>
          <pub-id pub-id-type="pmid">19332353</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
